由TAM衍生的外体miR-589-3p通过BCL2L13加速卵巢癌的进展
Jianqing Wang1, Yan Zhu1, Yang He1
1Department of Gynecology and Obstetrics, Yancheng First People's Hospital, Yancheng Clinical College of Xuzhou Medical University, Yancheng, Jiangsu, 224002, China.
Journal of ovarian research
|February 22, 2025
概括
瘤相关巨细胞 (TAM) 释放含有miR-589-3p的外体,通过向BCL2L13.3,促进卵巢癌 (OC) 的进展. 抑制这种外体微RNA为OC提供了潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 与瘤相关的巨细胞 (TAM) 是瘤微环境 (TME) 中的关键.
- 外体细胞介导瘤细胞和TME之间的细胞间通信.
- 微RNAs (miRNAs) 在卵巢癌 (OC) 的发展中起着至关重要的作用.
研究的目的:
- 调查TAM衍生的外体miR-589-3p在OC进展中的作用.
- 阐明 miR-589-3p 在 OC 中的功能背后的分子机制.
主要方法:
- 周围血液单核细胞 (PBMC) 极化为M2型巨细胞.
- 使用TEM和NTA对外体的隔离和表征.
- qRT-PCR用于定量基因表达.
- 生物信息预测和实验验证 (双化酶,RIP测定) 的miR-589-3p目标.
- 使用CCK-8和流细胞测量对OC细胞增殖和细胞亡的评估.
主要成果:
- 由TAM衍生的外体促进OC细胞的增殖,并抑制细胞亡.
- miR-589-3p的表达在与TAM衍生的外生细胞共同培养的OC细胞中得到上调.
- miR-589-3p直接准并与BCL2L13结合.
- 在TAM衍生的外体体中抑制miR-589-3p会减轻OC的进展.
结论:
- 由TAM衍生的外体miR-589-3p通过向BCL2L13.3来促进OC的进展.
- 这一发现为卵巢癌提供了一个新的治疗点.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


